Follow
Kathryn R. Wagner
Kathryn R. Wagner
VP, Global Head of Neuromuscular Disorders, F. Hoffmann La-Roche
Verified email at roche.com
Title
Cited by
Cited by
Year
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ...
The Lancet Neurology 9 (1), 77-93, 2010
24392010
Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke, KR Wagner, LE Stolz, C Hübner, T Riebel, W Kömen, ...
New England Journal of Medicine 350 (26), 2682-2688, 2004
18882004
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ...
The Lancet Neurology 9 (2), 177-189, 2010
14142010
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
DJ Birnkrant, K Bushby, CM Bann, SD Apkon, A Blackwell, D Brumbaugh, ...
The Lancet Neurology 17 (3), 251-267, 2018
11472018
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
KR Wagner, JL Fleckenstein, AA Amato, RJ Barohn, K Bushby, ...
Annals of neurology 63 (5), 561-571, 2008
6162008
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
KR Wagner, AC McPherron, N Winik, SJ Lee
Annals of Neurology: Official Journal of the American Neurological …, 2002
5752002
Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells
K Sadtler, K Estrellas, BW Allen, MT Wolf, H Fan, AJ Tam, CH Patel, ...
Science 352 (6283), 366-370, 2016
5482016
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
TA of the Safety
The Lancet 358 (9282), 605-613, 2001
4012001
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations
KR Wagner, S Hamed, DW Hadley, AL Gropman, AH Burstein, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
3732001
Telomere position effect: regulation of gene expression iwth progressive telomere shortening over long distances.
WWE Robin J D, Ludlow A T, Batten K, Magdinier F, Stadler G, Wagner K R ...
Genes Dev 28 (22), 2464-2476, 2014
3282014
Muscle regeneration in the prolonged absence of myostatin
KR Wagner, X Liu, X Chang, RE Allen
Proceedings of the national academy of sciences 102 (7), 2519-2524, 2005
3202005
Myostatin directly regulates skeletal muscle fibrosis
ZB Li, HD Kollias, KR Wagner
Journal of Biological Chemistry 283 (28), 19371-19378, 2008
3052008
Contemporary cardiac issues in Duchenne muscular dystrophy
EM McNally, JR Kaltman, DW Benson, CE Canter, LH Cripe, D Duan, ...
Circulation 131 (18), 1590-1598, 2015
2982015
Current treatment of adult Duchenne muscular dystrophy
KR Wagner, N Lechtzin, DP Judge
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1772 (2), 229-237, 2007
2152007
The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin
KR Wagner, JB Cohen, RL Huganir
Neuron 10 (3), 511-522, 1993
1971993
Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis
TI Jones, JCJ Chen, F Rahimov, S Homma, P Arashiro, ML Beermann, ...
Human molecular genetics 21 (20), 4419-4430, 2012
1932012
Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model
IY Choi, HT Lim, K Estrellas, J Mula, TV Cohen, Y Zhang, CJ Donnelly, ...
Cell reports 15 (10), 2301-2312, 2016
1682016
A randomized, pilot trial of etanercept in dermatomyositis
Muscle Study Group
Ann Neurol, 2011
1582011
In vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy
SR Choudhury, Z Fitzpatrick, AF Harris, SA Maitland, JS Ferreira, Y Zhang, ...
Molecular Therapy 24 (7), 1247-1257, 2016
1332016
Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study
KR Wagner, WH Giles, CJ Johnson, CY Ou, PF Bray, ...
Stroke 29 (3), 581-585, 1998
1321998
The system can't perform the operation now. Try again later.
Articles 1–20